Abstract

Huntington’s disease is a dominantly inherited neurodegenerative disorder caused by the expansion of a CAG repeat, encoding for the amino acid glutamine (Q), present in the first exon of the protein huntingtin. Over the threshold of Q39 HTT exon 1 (HTTEx1) tends to misfold and aggregate into large intracellular structures, but whether these end-stage aggregates or their on-pathway intermediates are responsible for cytotoxicity is still debated. HTTEx1 can be separated into three domains: an N-terminal 17 amino acid region, the polyglutamine (polyQ) expansion and a C-terminal proline rich domain (PRD). Alongside the expanded polyQ, these flanking domains influence the aggregation propensity of HTTEx1: with the N17 initiating and promoting aggregation, and the PRD modulating it. In this study we focus on the first 11 amino acids of the PRD, a stretch of pure prolines, which are an evolutionary recent addition to the expanding polyQ region. We hypothesize that this proline region is expanding alongside the polyQ to counteract its ability to misfold and cause toxicity, and that expanding this proline region would be overall beneficial. We generated HTTEx1 mutants lacking both flanking domains singularly, missing the first 11 prolines of the PRD, or with this stretch of prolines expanded. We then followed their aggregation landscape in vitro with a battery of biochemical assays, and in vivo in novel models of C. elegans expressing the HTTEx1 mutants pan-neuronally. Employing fluorescence lifetime imaging we could observe the aggregation propensity of all HTTEx1 mutants during aging and correlate this with toxicity via various phenotypic assays. We found that the presence of an expanded proline stretch is beneficial in maintaining HTTEx1 soluble over time, regardless of polyQ length. However, the expanded prolines were only advantageous in promoting the survival and fitness of an organism carrying a pathogenic stretch of Q48 but were extremely deleterious to the nematode expressing a physiological stretch of Q23. Our results reveal the unique importance of the prolines which have and still are evolving alongside expanding glutamines to promote the function of HTTEx1 and avoid pathology.

Highlights

  • Huntington’s disease (HD) is a monogenic hereditary neurodegenerative disorder caused by the expansion of a glutamine (Q, CAG) stretch in the first exon of the protein huntingtin (HTT) (The Huntington’s Disease Collaborative Research Group, 1993)

  • First appearance of the HTT gene dates back millennia and orthology studies have identified a primordial version of HTT in amoeba and the first appearance of a single glutamine amino acid in the sea urchin

  • We investigated and dissected the contribution of the domains flanking the polyQ stretch in HTT exon 1 (HTTEx1) and elucidated the specific contribution of the first pure repeat of prolines, the P1, immediately adjacent to the C-terminal of the polyQ

Read more

Summary

Introduction

Huntington’s disease (HD) is a monogenic hereditary neurodegenerative disorder caused by the expansion of a glutamine (Q, CAG) stretch in the first exon of the protein huntingtin (HTT) (The Huntington’s Disease Collaborative Research Group, 1993). HD is part of a class of nine disorders known as polyglutamine (polyQ) diseases that all share the same pathological culprit in a polyQ expansion. CAG repeats become pathological only above a defined threshold, which is specific for each disease, albeit similar (Zoghbi and Orr, 2000). For HD, the disorder is fully penetrant above the threshold of Q ≥ 39; for intermediate alleles of 35 < Q < 39 the disease might manifest late in life, whilst for Q ≤ 35, there is no pathology. HD causes atrophy of the basal ganglia, a result of the extensive loss of medium spiny neurons of the striatum (Walker, 2007)

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call